Viewing Study NCT03317457


Ignite Creation Date: 2025-12-24 @ 7:03 PM
Ignite Modification Date: 2026-02-18 @ 12:23 PM
Study NCT ID: NCT03317457
Status: COMPLETED
Last Update Posted: 2023-06-15
First Post: 2017-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma
Sponsor: AIO-Studien-gGmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module